Detailed Biography:
Dr. No-Hee Park is a prominent scientist in oral and craniofacial research, with more than 185 scientific publications in distinguished research journals. His major research activities have been in oral (head & neck) cancer and aging research. Dr. Park's contribution to the understanding of the mechanisms of oral cancer development is enormous, and resulted in new mode of therapy. In the early stage of his career (1975-1983), Dr. Park developed animal models to evaluate the therapeutic efficacy of antiviral agents and to study the molecular mechanisms of numerous antiviral agents (e.g., Zovirax®) against herpes simplex virus.
In later stages of his research career (since 1983), Dr. Park began to investigate the mechanisms of human oral cancer development. Initially, he found the combined carcinogenicity of herpes simplex virus (HSV: this virus causes cold sores around the human mouth) and cancer-causing chemicals found in tobacco. Then he investigated and clearly documented the combined role of tobacco (or chemical carcinogens derived from tobacco extract) and the virus on the development of oral cancer in laboratory animals. More recently, Dr. Park (1) developed an in vitro system (extremely useful for studying the mechanisms of oral cancer development) and clearly documented the role of human papillomavirus (HPV: this virus causes warts and may be related to other cancers) in the development of oral cancer; (2) clearly documented the close association between chromosome (cellular DNA) instability and cancer development; (3) developed many cell lines that are useful for cancer research; (4) documented a new aging model in test tubes, using cells derived from the human mouth; and (5) successfully converted normal human epithelial cells into mesenchymal cells, which were able to differentiate to bony cells and fat cells. Currently his major interests are in the areas of cellular aging, molecular carcinogenesis and stem cell research. Through his cancer and aging research, Dr. Park has provided significant contributions to enhance the wellbeing of individuals and society, particularly by elucidating the role of human papillomavirus in the development of human cancer.
Dr. Park’s research has been well funded by both NIH and private foundations, and he has been a member of many research organizations, including American Association for Advanced Science (AAAS), American Association for Cancer Research (AACR), International Association for Dental Research (IADR), American Society for Microbiology (ASM), etc. He has also served on Editorial Boards for many research journals, including European Journal of Cancer (Oral Oncology), Journal of Dental Research, International Journal of Oncology, Journal of Biotechnology, Odontology, and International Journal of Oral Biology. Additionally, for more than a decade, Dr. Park has served as a member of a number of NIH grant review committees for both the National Cancer Institute and the National Institute of Dental Research.
Dr. Park has received numerous awards and honors, and recognition by his peers, including the Distinguished Scientist Award from International Association for Dental Research (IADR), Alumnus of the Year Awards from Medical College of Georgia and Seoul National University (both School of Dentistry and University wide), the Award as the Most Achieved Dental Educator from the Gies /ADEA (American Dental Education Association) Foundation, the Silver Anniversary Award from Harvard University, No-Hee Park Endowed Chair at UCLA, Distinguished Professorship at UCLA, and AAAS (American Association for Advancement of Science) Fellow, etc.
Dr. Park received his DDS (Doctor of Dental Surgery) degree from the Seoul National University College of Dentistry in 1968 and a clinical certificate in Periodontics in 1971. He received his PhD in Pharmacology in 1978 from the Medical College of Georgia, completed his postdoctoral fellowship at the Harvard Medical School-affiliated Eye Research Institute and earned his DMD (Doctor of Medicine in Dentistry) degree from the Harvard School of Dental Medicine in 1982. He then served two years as faculty at Harvard Medical School and Harvard School of Dental Medicine, before joining the faculty of the UCLA School of Dentistry in 1984. He became Director of the UCLA Dental Research Institute in 1995, where he served until June 2002, and in 1997, he was appointed Associate Dean for Research at the School of Dentistry and created the UCLA Wound Healing Research Center.
As dean for 18 years, from 1998-2016, he directed a $90 million enterprise with 400 full and part-time faculty, 450 students (DDS, PhD, and MS Programs), 91 dental residents, over 100 foreign clinical trainees, and a staff of 300 employees. He has also trained more than 100 research students, postdoctoral fellows, and visiting faculty members from overseas during the past several decades. Most of his trainees are presently faculty members of dental schools, medical schools and colleges of life science in the United States and many other countries including Europe, Korea, Japan and China.
Publications:
A selected list of publications:
Gong D, Wu NC, Xie Y, Feng J, Tong L, Brulois KF, Luan H, Du Y, Jung JU, Wang CY, Kang MK, Park NH, Sun R, Wu TT.
Kaposi's sarcoma-associated herpesvirus ORF18 and ORF30 are essential for late gene expression during lytic replication
Journal of Virology,
2014; 88(19):
11369-82.
Zhang Lei, Xiao Hua, Zhou Hui, Santiago Silverio, Lee Jay M, Garon Edward B, Yang Jieping, Brinkmann Ole, Yan Xinmin, Akin David, Chia David, Elashoff David, Park No-Hee, Wong David T W
Development of transcriptomic biomarker signature in human saliva to detect lung cancer
Cellular and Molecular Life Sciences : CMLS,
2012; 69(19):
3341-50.
Tseng Han-Ching, Arasteh Aida, Paranjpe Avina, Teruel Antonia, Yang Wendy, Behel Armin, Alva Jackelyn A, Walter Gina, Head Christian, Ishikawa Tomo-o, Herschman Harvey R, Cacalano Nicholas, Pyle April D, Park No-Hee, Jewett Anahid
Increased lysis of stem cells but not their differentiated cells by
natural killer cells; de-differentiation or reprogramming activates NK
cells
PloS one,
2010; 5(7):
e11590.
Shin Ki-Hyuk, Kim Reuben H, Kang Mo K, Kim Roy H, Kim Steve G, Lim Philip K, Yochim Ji Min, Baluda Marcel A, Park No-Hee
p53 promotes the fidelity of DNA end-joining activity by, in part,
enhancing the expression of heterogeneous nuclear ribonucleoprotein G
DNA repair,
2007; 6(6):
830-40.
Li Y, St John MA, Zhou X, Kim Y, Sinha U, Jordan RC, Eisele D, Abemayor E, Elashoff D,Park NH, Wong DT
Salivary transcriptome diagnostics for oral cancer detection
Clinical cancer research : an official journal of the American Association for Cancer Research. ,
2004; 10(24):
8442-50.
Chow Yen-Hung, Yu Duan, Zhang Jun-Ying, Xie Yiming, Wei O Lu-Chen, Chiu Christopher, Foroohar Mani, Yang Otto O, Park No-Hee, Chen Irvin S Y, Pang Shen
gp120-Independent infection of CD4(-) epithelial cells and CD4(+)
T-cells by HIV-1
Journal of acquired immune deficiency syndromes (1999),
2002; 30(1):
1-8.
Pang, S., Kang, M., Kung, S, Yu, D., Lee, A., Poon, B., Chen, I.S.Y. and Park, N.-H.
Anticancer effect of lentiviral vector capable of expressing HIV-1 Vpr
Clinical Cancer Res,
2001; 7:
3567-3573.
Kim, H., Christensen, R., Kang, M., Park, Noh-Hyun, Sapp, P. and Park, N.-H.
Elevated expression of hTERT is associated with dysplastic cell transformation during human oral carcinogenesis in situ
Clinical Cancer Res,
2001; 7:
3079-3086.
Zhou, H, Lin, A., Gu, Z., Chen, S., Park, N.-H. and Chiu, R.
TPA-induced JNK phospatase inhibition required for JNK activity induced by TPA in immortalized or transformed epithelial cells
J. Biol. Chem,
2000; 275:
22868-22875.
Shuster, M.,I., Han, L., Le Beau, M.M., Davis, E., Sawicki, M., Lese, C.M., Park, N.-H., Colicelli, J., Gollin, S. M.
Consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines support a breakage-fusion-bridge cycle model for 11q13 amplification
Genes, Chromosomes, & Cancer ,
2000; 28:
153-163.
Guo, W., Baluda, M.A. and Park, N.-H.
Ethanol upregulates the expression of p21WAF1/CIP1 and prolongs G1 transition via a p53-independent pathway in human epithelial cells,
Oncogene,
1997; 15:
1143-1149.
Park, N.-H., Gujuluva, C.N., Baek, J.-H., Min, B.-M. Cherrick, H.M. and Shin, K.-H.
Combined oral carcinogenicity of HPV-16 and benzo(a)pyrene: An in vitro multistep carcinogenesis model
Oncogene,
1995; 10:
2145-2153.
Kim Reuben H, Kang Mo K, Kim Terresa, Yang Paul, Bae Susan, Williams Drake W, Phung Samantha, Shin Ki-Hyuk, Hong Christine, Park No-Hee
Regulation of p53 during senescence in normal human keratinocytes
Aging cell,
2015; 14(5):
838-46.
Mehrazarin Shebli, Chen Wei, Oh Ju-Eun, Liu Zi X, Kang Kyung L, Yi Jin K, Kim Reuben H, Shin Ki-Hyuk, Park No-Hee, Kang Mo K
The p63 Gene Is Regulated by Grainyhead-like 2 (GRHL2) through
Reciprocal Feedback and Determines the Epithelial Phenotype in Human
Keratinocytes
The Journal of biological chemistry,
2015; 290(32):
19999-20008.
Lee Sung Hee, Rigas Nicole Kristina, Lee Chang-Ryul, Bang April, Srikanth Sonal, Gwack Yousang, Kang Mo K, Kim Reuben H, Park No-Hee, Shin Ki-Hyuk
Orai1 promotes tumor progression by enhancing cancer stemness via NFAT
signaling in oral/oropharyngeal squamous cell carcinoma
Oncotarget,
2016; 7(28):
43239-43255.
Williams Drake W, Lee Cindy, Kim Terresa, Yagita Hideo, Wu Hongkun, Park Sil, Yang Paul, Liu Honghu, Shi Songtao, Shin Ki-Hyuk, Kang Mo K, Park No-Hee, Kim Reuben H
Impaired bone resorption and woven bone formation are associated with
development of osteonecrosis of the jaw-like lesions by bisphosphonate
and anti-receptor activator of NF-κB ligand antibody in mice
The American journal of pathology,
2014; 184(11):
3084-93.
Lee Dong-Keun, Kim Sue Vin, Limansubroto Adelheid Nerisa, Yen Albert, Soundia Akrivoula, Wang Cun-Yu, Shi Wenyuan, Hong Christine, Tetradis Sotirios, Kim Yong, Park No-Hee, Kang Mo K, Ho Dean
Nanodiamond-Gutta Percha Composite Biomaterials for Root Canal
Therapy
ACS nano,
2015; 9(11):
11490-501.
Lee Sung Hee, Park Yongtae, Song Minju, Srikanth Sonal, Kim Sol, Kang Mo K, Gwack Yousang, Park No-Hee, Kim Reuben H, Shin Ki-Hyuk
Orai1 mediates osteogenic differentiation via BMP signaling pathway in
bone marrow mesenchymal stem cells
Biochemical and biophysical research communications,
2016; 473(4):
1309-1314.
Kim Sol, Williams Drake W, Lee Cindy, Kim Terresa, Arai Atsushi, Shi Songtao, Li Xinmin, Shin Ki-Hyuk, Kang Mo K, Park No-Hee, Kim Reuben H
IL-36 Induces Bisphosphonate-Related Osteonecrosis of the Jaw-Like
Lesions in Mice by Inhibiting TGF-β-Mediated Collagen Expression
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
2017; 32(2):
309-318.
Sohn S, Park Y, Srikanth S, Arai A, Song M, Yu B, Shin K-H, Kang M K, Wang C, Gwack Y, Park N-H, Kim R H
The Role of ORAI1 in the Odontogenic Differentiation of Human Dental
Pulp Stem Cells
Journal of dental research,
2015; 94(11):
1560-7.